2.20 "Courageous Skeptics", Lenalidomide, QOTW, and a Political Conversation with Dr. Andy Saultz

Plenary Session

Vinay Prasad, MD MPH

Medicine, Policy, Health, Science & Medicine, Oncology

4.8 • 799 Ratings

🗓️ 1 November 2019

⏱️ 156 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

We begin this week's episode with a thoughtful discussion of the internet's "courageous skeptics". Then, after lamenting the way in which the recent study "Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma" was conducted, we end with an interview with Dr. Andy Saultz on his ongoing campaign for Oregon state representative. We break up the interview with a couple Hem/Onc boards questions of the week from Dr. Emerson Chen. Lenalidomide in Smoldering Multiple Myeloma: doi.org/10.1200/JCO.19.01740 Back us on Patreon! www.patreon.com/plenarysession

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Plenary Session.
0:07.0	I'm your host, Dr. Vinay Prasad.
0:10.0	I'm a practicing hematologist, oncologist, and I'm associate professor of medicine.
0:14.0	I'm interested in issues at the intersection of medicine, oncology, and health policy, and that's what you're going to get on this podcast.
0:22.2	Welcome to Season 2.
0:25.1	This week on Plenary Session, we have a lot of good stuff in store for you.
0:29.0	We have an interview with Dr. Andy Sulse.
0:31.3	He's running for political office.
0:33.1	So warning, this is going to be a political interview.
0:35.5	It is not the Stock and trade plenary session
0:37.9	interview. We're going to talk about politics. We may even take stances on political issues. So if
0:43.2	you're not interested in hearing about politics, if you want to keep this science and medicine,
0:47.8	then don't listen to this interview. But if you are willing to go into the political arena,
0:52.3	you have a great interview in store for you. And before we go to the interview, I got two things I want to talk about.
0:57.0	One, I want to talk about skepticism and where it is best placed, and two, I want to talk about a randomized control trial that appeared in the JCO that claims to say,
1:07.0	we ought to treat patients with high-risk molding myeloma with Revlimid, and we will examine whether or not that really is the take-home message of that clinical study.
1:14.7	So you won't want to miss this episode.
1:16.6	Stay tuned.
1:18.9	But first, a thanks.
1:20.6	I want to thank those of you who've gone online and support this podcast on patreon.com.
1:25.7	Patreon subscribers get access to the slides from lectures I give on plenary session.
1:30.4	I also want to thank the hundreds of you who've gone to the iTunes store and reviewed
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.